![Brad Rees](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brad Rees
Presidente presso G2 Therapies Pty Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Peter Whitfeld | M | - |
G2 Therapies Pty Ltd.
![]() G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | - |
Charles Reay Mackay | M | - |
G2 Therapies Pty Ltd.
![]() G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | 22 anni |
Andrew Adamovich | M | - |
G2 Therapies Pty Ltd.
![]() G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | - |
Terri Faroe | F | - |
G2 Therapies Pty Ltd.
![]() G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | - |
David Barda | M | - |
G2 Therapies Pty Ltd.
![]() G2 Therapies Pty Ltd. BiotechnologyHealth Technology G2 Therapies Pty Ltd. develops novel antibody based therapies in inflammation and cancer. G2 used novel techniques to raise potent neutralising antibodies to the entire cell surface target of several 7-transmembrane domain chemoattractant receptors (GPCRs). The company was founded by Charles Reay Macaky in 2002 and is headquartered in Darlinghurst, Australia. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Australia | 5 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Brad Rees
- Contatti personali